The Holocaust and the racial hygiene doctrine that helped rationalize it still overshadow contemporary debates about using gene editing for disease prevention.

In the 1910s, the American Medical Association fought quackery promoted in pamphlets for drugs and treatments for everything from teething to epilepsy.

With a focus on health justice, literature review suggests possible relationships between HPV type and geography and demonstrates that insurance status matters.

Genome editing raises old questions, but CRISPR arose in a political landscape that vastly differs from the early aughts.

As machine learning becomes increasingly common in health care, these systems’ data, algorithms, and recommendations raise critical justice questions.

Dr Sean C. McConnell provides an introduction to gene editing, and Scott J. Schweikart discusses what prudent governance requires.

Proliferation of innovative procedures and treatments in surgery has led to novel and distinct ethical challenges. Medicine can learn from plastic surgeons’ approaches to informed consent and potentially harmful treatments.

Emergency research that requires exception from informed consent presents challenges in defining and reaching the at-risk community.

Direct-to-consumer genetic testing requires that physicians share decision making with patients, not order unnecessary tests or interventions, and refer to genetic specialists when necessary.